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Volume 57, Number 5S Abstracts 27S(4 year mean follow). Stenosis was graded using a combina-
tion of velocities and velocity ratios, including PSVic/
EDVcc, into six groups: 50%-60%, 60%-70%, 70%-80%,
80%-90%, 90%-95% or 95%-99%. Progression or regression
was considered present if there was a change to adjacent
groups that persisted for at least two consecutive visits.
Results: Regression occurred in 43 (3.8%), no change
in 856 (76.4%), progression in 190 (17.0%) and occlusion
in 32 (2.8%) patients. Ipsilateral ischemic event rate was 0%
with regression, 10.3% with no change, 17.4% with
progression and 28.1% with occlusion (c2, P < .001).
The corresponding values for stroke were 0%, 4.7%. 7.9%
and 12.5%, respectively (c2, P ¼ .029).
Using Kaplan-Meier curves, in the subgroup of patients
with stenosis 70-95% the average annual ipsilateral ischemic
event rate was 2.25% in patients with regression or absence
of change and 4.75% in patients with progression (P <
.001; OR, 2.15, 95% CI, 1.44-3.21). The corresponding
values for stroke were 1.12% and 2.50% (P ¼ .025; OR,
2.01, 95% CI, 1.14-3.54). In the subgroup of occlusion
the average annual ipsilateral ischemic event rate was
5.6% and for stroke 2.6%.
In a logistic regression analysis, the severity of the ﬁnal
stenosis (P ¼ .005; OR, 1.28; 95% CI, 1.08-1.53) and
progression (P ¼ .034; OR, 1.47; 95% CI, 1.03-2.10)
were both independent predictors of ipsilateral ischemic
events.
Conclusions: The degree of stenosis and progression
are both associated with the occurrence of ischemic events
and stroke. Progression identiﬁes a group at increased risk
of stroke.
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Natural History of Asymptomatic Severe Carotid
Artery Stenosis
Mark F. Conrad, Shankha Mukhopadhyay, Michael J.
Michalczyk, Arissa Opalacz, Glenn M. LaMuraglia,
Richard P. Cambria. Vascular Surgery, Massachusetts
General Hospital, Boston, Mass
Objectives: Although level-1 evidence supports
carotid endarterectomy (CEA) for stroke prevention in
patients with asymptomatic severe (>70%) carotid stenosis
(ASCAS), medical therapy has been promulgated by some
as equally effective. The goal of this study is to determine
the natural history of medically treated ASCAS.
Methods: Patients with ASCAS were identiﬁed by
Duplex (index study 2005-06) and included if they were
treated with medical therapy (for comorbidities or patient
preference). Patients were excluded if they had a carotid
intervention within 6 months of the index Duplex. Aspirin
and statin use (including LDL) was recorded for each
patient. The mean follow-up was 52 months. Study
endpoints included: ipsilateral neurologic symptoms (INS)
(stroke/tia) and death.Results: There were 126 carotid arteries in 115pts. 88
(70%) had severe (70%-89%) and 38 (30%) had very severe
(90%-99%) stenoses (VSS). Demographics: age 73.5 years,
5% chronic kidney disease (CKD), 86% were on statins
(28% had LDL <100 mg/dL) and 88% were on aspirin.
31 (25%) patients developed INS during follow-up and
most 23/31 (74%) occurred within 12 months of the initial
DUS; 45% of INS were strokes. The 5-year actuarial
freedom from INS was 70.1%+/5%. Multivariate predic-
tors of INS included: VSS (HR, 3.23; CI, 1.56-6.76; P ¼
.002), CKD (HR, 6.25; CI, 2.05-19.2; P ¼ .001), age
(HR, .94; CI, .91-0.98; P ¼ .001). 41 (33%) patients
underwent eventual carotid revascularization (32 CEA, 9
Stent); 56% were performed for INS and 44% for plaque
progression. The 5-year actuarial survival was 69.8%+/
4.1%. Multivariate predictors of death included: Age
(HR, 1.06; CI, 1.03-1.1; P ¼ .0001), COPD (HR, 1.92;
CI, 1.08-3.41; P ¼ .03) and DM (HR, 5.08; CI, 2.86-
9.01; P < .0001). Neither statin nor aspirin use was protec-
tive in this cohort.
Conclusions: Medically managed patients with
ASCAS develop INS early; especially those with >90%
stenosis. The natural history of medically treated ASCAS
and failure of aspirin/statins to prevent INS supports
the continued role of CEA as ﬁrst line therapy in these
patients.
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M. F. Conrad: Nothing to disclose; G. M. LaMuraglia:
Nothing to disclose; M. J. Michalczyk: Nothing to
disclose; S. Mukhopadhyay: Nothing to disclose; A. Opa-
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Video Presentation
Novel Carotid Reconstruction Technique
Mario Avila. Northwest Medical Cardiac & Vascular
Center, Margate, Fla
Background: To demonstrate a novel and simple
Carotid Endarterectomy technique that results in a shorter
procedure, decreased recovery time, lesser risk of complica-
tions and signiﬁcant cost reduction.
Technical Description: This procedure consists of
a mini arteriotomy (12 to 14 mm long) on the front
wall of the internal carotid’s widest origin “without”
transecting the artery completely as in the classical ever-
sion technique.
Eversion endarterectomy is done from below the bifur-
cation distally into the external and internal simultaneously.
There are several advantages:
a. The back wall of the artery remains intact, therefore
less chances of suture line proliferation or recurrence.
b. Easy to prolong arteriotomy and correct a question-
able distal endpoint (contrary to the standard
complete transection)
c. Avoid prosthetic patch preventing infection, pseudoa-
neurysm, or suture line bleeding
d. Signiﬁcant reduced clamping time
e. Considerable reduction in the cost of OR time, anes-
thesia, PACU, and LOS
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We no longer perform the classical complete transection
and eversion endarterectomy after gaining experience and
success with our technique.
Results: During the last three years, we selected 100
patients for this procedure. Every patient woke up immedi-
ately from the anesthesia without neurological deﬁcits,
hematomas, nerve injuries or cardiac complications. Overall
the perioperative results are excellent.
Conclusions: This approach is feasible, safe, simple,
and an effective method of intervention for carotid
reconstruction.
Author Disclosures: M. Avila: Nothing to disclose.Table. Incidence of SCI according to extent of
endograft repair
Type of repair No. (%) Incidence of SCI, No. (%)
Total 1251 (100) 36 (2.9)
AAA 351 (28) 1 (0.3)
Juxtarenal AAA 213 (17) 1 (0.5)
TAA 194(16) 10 (5.2)
TAAA 493 (39) 24 (4.9)
SCI, Spinal cord ischemia; AAA, abdominal aortic aneurysm; TAA, thoracic
aortic aneurysm, TAAA, thoracoabdominal aortic aneurysmSS14.
Predictors and Consequences of Unplanned Hospital
Readmission Within 30 Days of Carotid
Endarterectomy
Karen J. Ho1, Arin L.Madenci2, James T.McPhee3,Marcus
E. Semel1, Louis L.Nguyen1, C.K.Ozaki1,Michael Belkin1.
1Surgery, Brigham and Women’s Hospital, Boston, Mass;
2University of Michigan Medical School, Ann Arbor,
Mich; 3Boston Medical Center, Boston, Mass
Objectives: Carotid endarterectomy (CEA) is the
operation vascular surgeons perform most frequently in
the US. Given the resource burden of unplanned readmis-
sions (URA), we sought to identify the predictors/conse-
quences of URA within 30 days (d) of CEA for potential
points of intervention.
Methods: Retrospective analysis of consecutive CEAs
(2001-2011) at a single institution. Primary endpoint was
URA within 30d. Factors crudely associated with URA at
P < .05 were included in the stepwise multivariable anal-
ysis. Death through 1 year was compared with the log
rank test for the Kaplan-Meier estimator.
Results: 840 patients underwent 896 CEAs. Median
postop LOS was 1 day (interquartile range [IQR], 1-2).
Overall 30d readmission rate was 8.6% and URA rate was
6.5%. The most frequent reasons for URA were cardiac,
other medical complications and headache. Nearly half of
the URA patients (27, 46.5%) were readmitted for
a CEA-related reason (headache, cardiac, hypertension,
wound infection, bleeding/hematoma, stroke/TIA,
dysphagia, hyperperfusion syndrome). 16 (27.5%) patients
had more than one reason for URA. Median time to
URA was 4d (IQR 1-9). Unadjusted risk factors for URA
were history of CAD, CABG, or CHF and postop in-
hospital occurrence of stroke, bleeding/hematoma, myocar-
dial infarction or CHF. Hospital LOS, indication for CEA
and discharge destination were not associated with URA.
In multivariable analysis, prior CABG (adjusted odds ratio
[OR], 2.2, 95% CI, 1.2-3.9; P ¼ .009) and postop in-
hospital stroke(OR, 7.1, 95% CI, 2.0-25.1; P ¼ .003),
bleeding/hematoma (OR, 3.3; 95% CI, 1.4-8.2; P ¼
.009) and CHF (OR, 55.2, 95% CI, 5.5-52.5; P ¼ .006)
were signiﬁcantly associated with URA. URA was associated
with increased mortality over 1 year (log rank test, P ¼ .02).
Conclusions: The 30-day URA rate after CEA is low
(6.5%). Prior CABG and in-hospital postop occurrence of
stroke, bleeding/hematoma and CHF identify those atincreased risk of URA. URA may signal increased long-
term risk of postoperative mortality.
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Collateral Bed Patency Affects Outcomes of Spinal
Cord Ischemia (SCI) Following Aortic Endografting
Matthew J. Eagleton, Samir K. Shah, Daniel Petkovsek,
Tara Mastracci, Roy K. Greenberg. Vascular Surgery,
Cleveland Clinic, Cleveland, Ohio
Objectives: This study evaluated factors affecting
outcomes from SCI associated with endovascular aortic
aneurysm repair.
Methods: 1251 patients enrolled in an IDE endograft
trial (1998-2010) were screened for SCI. A records review
supplemented prospective outcomes data. Demographics,
collateral bed (hypogastric (HA) and subclavian (SA)
artery) patency, presentation, and outcomes were evaluated
on patients with SCI.
Results: SCI occurred in 2.9% (Table) of patients.
Among SCI patients, SA bypass was performed in four
(13%) patients, and two had intraoperative SA coverage.
Preoperative HA occlusion was present in 14 (31%), and
an additional seven had intraoperative HA occlusion. SCI
was immediately apparent in 15 (42%) patients. The pres-
ence of an occluded SA or HA increased the risk of imme-
diate onset of SCI symptoms compared to those with
patent collaterals (73% vs 24%; P ¼ .021). Of those pre-
senting in a delayed fashion, nine (43%) had a clear precip-
itating event prior to SCI onset. Recovery occurred in 24
(67%) patients. Immediate onset was a negative predictor
of recovery (P ¼ .025), as was occlusion of a single collat-
eral bed (P ¼ .035). Mean follow up was 22 6 4 months,
with 30-day and 1-year survival of 92 6 4.6% and 56 6
8.3%. Survival at 3 months was lower in those that did
not recover from SCI symptoms (36% v. 92%; P < .001).
Conclusions: Single collateral bed occlusion predicts
immediate onset SCI and lack of recovery, which portends
increased mortality. Collateral bed preservation may limit
this complication following endovascular AA repair.
